Exclusive

Publication

Byline

Location

In Novartis patent case, India has a BIT of cover

India, Sept. 23 -- The Indian Patent Office (IPO) has revoked the patent of Novartis for its blockbuster cardiac drug, Vymada, based on a lack of novelty and inventive steps as required under the Pate... Read More


In Novartis patent case, India has a BIT of cover

India, Sept. 22 -- The Indian Patent Office (IPO) has revoked the patent of Novartis for its blockbuster cardiac drug, Vymada, based on a lack of novelty and inventive steps as required under the Pate... Read More


Resisting the coercive new global trade order

India, Aug. 15 -- How should India respond to the challenges posed by the US tariffs of 50%? Some believe that this crisis presents an opportunity for India to implement deeper economic reforms aimed ... Read More


Tariffs as a tool to extort, and slight India's sovereignty

India, Aug. 2 -- US President Donald Trump, in an executive order dated July 31, announced imposing an additional 25% tariff on all Indian imports, on grounds of national emergency and lack of recipro... Read More


Tariffs as a tool to extort, and slight India's sovereignty

India, Aug. 1 -- US President Donald Trump, in an executive order dated July 31, announced imposing an additional 25% tariff on all Indian imports, on grounds of national emergency and lack of recipro... Read More


India-UK FTA: A bold pathway to closer trade ties

India, July 26 -- India and the United Kingdom (UK) have signed a historic free trade agreement (FTA). Coming on the heels of India's other key FTAs with Australia and the UAE, the India-UK FTA promis... Read More


India-UK FTA: A bold pathway to closer trade ties

India, July 25 -- India and the UK have signed a historic free trade agreement (FTA). Coming on the heels of India's other key FTAs with Australia and the UAE, the India-UK FTA promises to give a sign... Read More